N-[(6-amino-2-pyridinyl)sulfonyl]-6-(2-fluoro-4-methylphenyl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide
C27H25FN4O4S — CID 121250526
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(6-amino-2-pyridinyl)sulfonyl]-6-(2-fluoro-4-methylphenyl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide
N-[(6-amino-2-pyridinyl)sulfonyl]-6-(2-fluoro-4-methylphenyl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide (PubChem CID 121250526) has the molecular formula C27H25FN4O4S and a molecular weight of 520.59 g/mol. Its IUPAC name is N-[(6-amino-2-pyridinyl)sulfonyl]-6-(2-fluoro-4-methylphenyl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[(6-amino-2-pyridinyl)sulfonyl]-6-(2-fluoro-4-methylphenyl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide |
|---|---|
| PubChem CID | 121250526 |
| Molecular Formula | C27H25FN4O4S |
| Molecular Weight | 520.59 g/mol |
| Exact Mass | 520.16 |
| IUPAC Name | N-[(6-amino-2-pyridinyl)sulfonyl]-6-(2-fluoro-4-methylphenyl)-2-(2,4,6-trimethylphenoxy)pyridine-3-carboxamide |
| SMILES | Cc1cc(C)c(Oc2nc(-c3ccc(C)cc3F)ccc2C(=O)NS(=O)(=O)c2cccc(N)n2)c(C)c1 |
| InChI | InChI=1S/C27H25FN4O4S/c1-15-8-9-19(21(28)14-15)22-11-10-20(26(33)32-37(34,35)24-7-5-6-23(29)31-24)27(30-22)36-25-17(3)12-16(2)13-18(25)4/h5-14H,1-4H3,(H2,29,31)(H,32,33) |
| InChIKey | YHASXEQPGZHGCY-UHFFFAOYSA-N |
| XLogP | 5.01 |
| TPSA | 124.27 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 520.59 |
| LogP ≤ 5 | 5.01 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121250526 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.